This study showed that the 28-gene signature previously reported to be prognostic of breast cancer and ovarian cancer clinical outcome is also diagnostic of breast cancer and can classify invasive cancer tumors from normal and ADH tissues. This evidence concerns the gene AVP and ovarian carcinoma.